Explainable histomorphology-based survival prediction of glioblastoma, IDH-wildtype

AI can identify survival-related patterns in brain tumor images that pathologists may overlook: The study found seven distinct histomorphological groups associated with patient survival, including both established prognostic features and "unexpected associations," suggesting the AI framework discovered clinically relevant patterns that weren't previously recognized as prognostically important.

Explainability is essential for clinical AI adoption: Rather than using a "black box" approach, the researchers combined multiple AI techniques (multiple instance learning and sparse autoencoders) specifically to make the model's decisions interpretable to human experts—three neuropathologists were able to validate and categorize the AI-identified patterns, which is crucial for doctors to trust and act on AI recommendations.

Real-world validation across multiple hospitals strengthens AI credibility: The model was trained and tested on 720 glioblastoma cases from three hospitals and four cancer registries across Germany, plus validated on 1,878 images from five independent public collections, demonstrating that the findings aren't limited to a single institution and are more likely to generalize to other patients.

AI predictions remain modest but meaningful complements to existing methods: With an AUC of 0.67 (where 0.5 is random guessing and 1.0 is perfect), the model showed "some ability" to distinguish between short-term and long-term survivors based on histology alone, and importantly, its predictions remained significant even after accounting for established prognostic factors—suggesting it captures additional prognostic information rather than replacing current clinical knowledge.